Are Lung Cancer Screening Guidelines Adequate for High-Risk Minorities?
IASLC Unveils Comprehensive Assessment of Liquid Biopsy for Patients With NSCLC
Can Simplified Screening Methods Accurately Indicate Pathology in NSCLC?
World Lung Cancer Day Commemorated by International Respiratory Societies
Addition of Biomarker Panel to Lung Cancer Screening: Can It Improve Detection of Disease?
Retrospective Analysis of Brain Metastases in Patients With Stage IV NSCLC
Does Prior Antibiotic Use Affect Treatment Outcomes in Lung Cancer?
Brigatinib Active in Patients With ALK-Positive Lung Cancer
NCCN Pharmacy Updates: The Evolving Landscape of Immunotherapy and Targeted Therapy for Non–Small Cell Lung Cancer
Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Non-Small Cell Lung Cancer
Sustaining Change in Quality Improvement for NSCLC – Part 3
The Emerging Role of Molecular Testing in an Era of Precision Medicine - Non–Small Cell Lung Cancer
Fred and Pamela Buffett Cancer Center
Mayo Clinic Cancer Center
University of Wisconsin Carbone Cancer Center
University of Colorado Cancer Center
Dabrafenib + Trametinib
Bonnie J. Addario Lung Cancer Foundation
Free to Breathe
Caring Ambassadors Program
Lung Cancer Alliance